The Tech The Tech Subscribe to our newsletter Newsletter
  • Home
  • News
  • Opinion
  • Arts
  • Sports
  • Campus Life
  • Science
  • About Us
  • Past Issues
  • Photos
  • Policies
  • Advertising
  • Sponsors
  • Donate
  • Our Staff
  • Join The Tech
  • Contact Us
  • Facebook
  • Twitter

Andrew Pollack



View Photographer Profile
World and Nation

US to increase production of experimental Ebola drug

By Andrew Pollack Oct. 3, 2014

U.S. federal officials are planning to sharply increase production of ZMapp, which is viewed by many experts as the most promising experimental drug for treating people stricken by Ebola in West Africa.

News

New cancer drug gets FDA approval

By Andrew Pollack Sep. 5, 2014

The Food and Drug Administration on Thursday approved the first of an eagerly awaited new class of cancer drugs that unleash the body’s immune system to fight tumors.

World and Nation

French company Sanofi says dengue vaccine succeeds in late-stage trial

By Andrew Pollack Apr. 29, 2014

LOS ANGELES — The French pharmaceutical company Sanofi said Monday that its experimental vaccine for dengue fever had succeeded in its first late-stage clinical trial. The results could help pave the way for introduction of the first vaccine to prevent a disease that afflicts as many as 100 million people a year.

World and Nation

Two companies aim to treat allergies with pills or drops

By Andrew Pollack Dec. 6, 2013

For much of her adult life, Shirley Hickey received two injections a week in an effort to tame severe allergies that caused frequent sore throats and sinus infections. Now she uses a less painful method.

News

Nelson Mandela, 95, passes away Thursday night

By Andrew Pollack Dec. 6, 2013

Nelson Mandela, who led the emancipation of South Africa from white minority rule and served as his country’s first black president, becoming an international emblem of dignity and forbearance, died Thursday night. He was 95.

News

Experimental treatment for muscular dystrophy

By Andrew Pollack Sep. 24, 2013

Terri Ellsworth is convinced that her 12-year-old son Billy, who has Duchenne muscular dystrophy, is being helped by an experimental drug that counteracts the genetic mutation causing his disease.

News

Former biotech king, dethroned and jailed

By Andrew Pollack Sep. 6, 2013

He was once hailed as the king of biotechnology. In the industry’s frontier days, David Blech was the top gunslinger, quick to draw his checkbook to start new companies or prop up faltering ones.

World and Nation

Cancer physicians attack high drug costs

By Andrew Pollack Apr. 26, 2013

With the cost of some lifesaving cancer drugs exceeding $100,000 a year, more than 100 influential cancer specialists from around the world have taken the unusual step of banding together in hopes of persuading some leading pharmaceutical companies to bring prices down.

World and Nation

Unsafe practices found at compounding pharmacies

By Andrew Pollack Apr. 12, 2013

After a crash inspection program, federal regulators said Thursday that they had found numerous unsafe practices at about 30 compounding pharmacies, the same type of facility responsible for the tainted drug that caused a deadly meningitis outbreak last year.

World and Nation

FDA approval for genetic drug to treat a rare inherited disorder

By Andrew Pollack Jan. 30, 2013

The Food and Drug Administration approved a new drug Tuesday that not only treats a rare inherited disorder that causes extremely high cholesterol levels and heart attacks by age 30 but does so using a long-sought technology that can shut off specific genes that cause disease.

News

More light shed on health violations

By Sabrina Tavernise and Andrew Pollack Oct. 23, 2012

The Massachusetts Department of Health released hundreds of pages of documents Monday detailing a history of violations at the New England Compounding Center, whose tainted medicine has caused a nationwide meningitis outbreak. The documents include dozens of complaints from as early as April 1999, less than a year after the company began as a compounding pharmacy in Framingham, Mass.

News

DNA sequencing bottlenecked in a deluge of data

By Andrew Pollack Dec. 2, 2011

BGI, based in China, is the world’s largest genomics research institute, with 167 DNA sequencers producing the equivalent of 2,000 human genomes a day.

News

Mosquitoes genetically altered

By Andrew Pollack Nov. 1, 2011

These mosquitoes are genetically engineered to kill — their own children.

News

Amgen to pay $780 million to settle suits on its sales

By Andrew Pollack Oct. 25, 2011

Amgen said Monday that it had set aside $780 million to settle various federal and state investigations and whistle-blower lawsuits accusing it of illegal sales and marketing tactics.

News

In cancer research, a new target: tumors’ fuel line

By Andrew Pollack Nov. 30, 2010

For the last decade cancer drug developers have tried to jam the accelerators that cause tumors to grow. Now they want to block the fuel line.

News

RNAi Therapeutics May Hold Key to Reducing Cholesterol

By Andrew Pollack Nov. 14, 2008

People whose bodies make an unusually active form of a certain protein tend to have dangerously high levels of cholesterol. Those with an inactive form of the protein have low cholesterol and a low risk of heart attacks.

World and Nation

FDA Announces That Food From Clones Is Safe for Humans to Eat

By Andrew Martin and Andrew Pollack Jan. 16, 2008

After years of debate, the Food and Drug Administration on Tuesday declared that food from cloned animals and their progeny is safe to eat, clearing the way for milk and meat derived from copies of prized dairy cows, steers and hogs to be sold at the grocery store.

The Tech
  • The Tech
  • 84 Massachusetts Ave, Suite 483
  • Cambridge, MA 02139-4300
  • 617.253.1541
  • Home
  • News
  • Opinion
  • Arts
  • Sports
  • Campus Life
  • Science
  • About Us
  • Past Issues
  • Policies
  • Advertising
  • Donate
  • Our Staff
  • Join The Tech
  • Contact Us
  • Facebook
  • Twitter
  •  
  •  
  •  
  • © 2025 The Tech